BR9604818A - Combination compositions containing benazepril or benazeprilat and valsartan - Google Patents

Combination compositions containing benazepril or benazeprilat and valsartan

Info

Publication number
BR9604818A
BR9604818A BR9604818A BR9604818A BR9604818A BR 9604818 A BR9604818 A BR 9604818A BR 9604818 A BR9604818 A BR 9604818A BR 9604818 A BR9604818 A BR 9604818A BR 9604818 A BR9604818 A BR 9604818A
Authority
BR
Brazil
Prior art keywords
benazeprilat
valsartan
compositions containing
combination compositions
containing benazepril
Prior art date
Application number
BR9604818A
Other languages
Portuguese (pt)
Inventor
David Saul Cohen
Gasparo Marc De
Randy Lee Webb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9604818A publication Critical patent/BR9604818A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9604818A 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan BR9604818A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (1)

Publication Number Publication Date
BR9604818A true BR9604818A (en) 1998-06-09

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9604818A BR9604818A (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (en)
JP (1) JPH11503139A (en)
KR (1) KR19980703647A (en)
CN (1) CN1181019A (en)
AU (1) AU5399096A (en)
BR (1) BR9604818A (en)
CA (1) CA2214143A1 (en)
CZ (1) CZ313897A3 (en)
HU (1) HUP9801593A2 (en)
MX (1) MX9707683A (en)
NO (1) NO974400L (en)
PL (1) PL322529A1 (en)
SK (1) SK133897A3 (en)
TR (1) TR199701121T1 (en)
WO (1) WO1996031234A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU716519B2 (en) * 1995-06-30 2000-02-24 Laboratoires Merck Sharp & Dohme - Chibret Snc Method of treating renal disease using an ace inhibitor and an A II antagonist
CN101011390A (en) 1999-01-26 2007-08-08 诺瓦提斯公司 Use of angiotensin II receptor antagonists for treating acute myocardial infarction
PL365696A1 (en) * 2000-04-12 2005-01-10 Novartis Ag Combination of organic compounds
ES2309090T3 (en) 2000-07-19 2008-12-16 Novartis Ag SALTS OF VALSARTAN.
EP1671632A1 (en) * 2000-08-22 2006-06-21 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
WO2002049645A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (en) * 2002-07-05 2008-04-02 安徽省生物医学研究所 Compound medicine for predicting ACEI pressure reducing medicine effect
AU2003268219B2 (en) * 2002-08-28 2009-09-24 Barnes-Jewish Hospital Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (en) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 Antihypertensive medical composite
DK2432452T3 (en) 2009-05-20 2016-10-10 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutically telmisartan drink solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
EP3099328A1 (en) * 2014-01-31 2016-12-07 Janssen Pharmaceutica NV Methods for the treatment and prevention of renal disorders and fatty liver disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097208T3 (en) * 1990-05-11 1997-04-01 Pfizer COMPOSITIONS AND THERAPEUTIC AND SYNERGIC PROCEDURES.
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
NO974400D0 (en) 1997-09-23
CZ313897A3 (en) 1998-01-14
TR199701121T1 (en) 1998-03-21
WO1996031234A1 (en) 1996-10-10
CN1181019A (en) 1998-05-06
AU5399096A (en) 1996-10-23
CA2214143A1 (en) 1996-10-10
HUP9801593A2 (en) 1999-01-28
PL322529A1 (en) 1998-02-02
JPH11503139A (en) 1999-03-23
EP0820302A1 (en) 1998-01-28
SK133897A3 (en) 1998-02-04
NO974400L (en) 1997-09-23
MX9707683A (en) 1997-12-31
KR19980703647A (en) 1998-12-05

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
DE69637691D1 (en) AZEOTROPÄHNLICHE COMPOSITIONS AND THEIR USE
DE69638056D1 (en) AZEOTROPÄHNLICHE COMPOSITIONS AND THEIR USE
ATE272067T1 (en) AMINOALKYL-GLUCOSAMINE PHOSPHATE COMPOUNDS AND THEIR USE AS ADJUVANTS AND IMMUNOEFFECTORS
DE69506095T2 (en) Dietary composition containing dietary fibers
BR9505368A (en) Cosmetic or dermatogogic composition water-in-oil
FI973475A (en) The composition and the product containing it
BR9609831A (en) Antipruritic cosmetic and / or pharmaceutical compositions
DE69513307D1 (en) COMPOSITION AND USE
BR9604818A (en) Combination compositions containing benazepril or benazeprilat and valsartan
BR9607058A (en) Composition
BR9606809A (en) Insecticide-active composition
PT728814E (en) BETUMINOUS COMPOSITION
DE69633937D1 (en) POLYAMIDE OR POLYESTER COMPOSITION
HUP9802997A3 (en) Antisudorific and/or deodorant compositions
BR9609903A (en) Insecticide-active composition
DE69616374D1 (en) GERMIZIDE COMPOSITION
DE69605016D1 (en) Intumescent composition
GB9724859D0 (en) Compounds and their use as antibacterial agents
FR2739382B1 (en) RIBOSOMAL FRACTION AND COMPOSITION CONTAINING THE SAME
BR9610382A (en) Cableo treatment composition
BR9607946A (en) Composition
DE59505197D1 (en) Safety combination
ATE183114T1 (en) SOLID COMPOSITION
FR2747308B1 (en) ASSOCIATION OF MARGOUSIER, (-) HYDROXYCITRATE AND CERAMIDES AND COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law